Crispr Therapeutics
CRSP
Insider trades and stock quote 2024-2026
All insider trades at Crispr Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
5/29/2026
|
Sell |
Patel, Naimish |
Chief Medical Officer |
$55.6 |
$210,577 |
|
3/23/2026
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$46.8 |
$173,460 |
|
3/23/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$46.8 |
$468,736 |
|
3/23/2026
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$46.8 |
$148,854 |
|
3/16/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$48.3 |
$499,443 |
|
3/16/2026
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$48.3 |
$166,497 |
|
3/16/2026
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$48.3 |
$476,277 |
|
3/16/2026
|
Sell |
Patel, Naimish |
Chief Medical Officer |
$48.3 |
$152,019 |
|
3/11/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$52.8 |
$517,334 |
|
3/11/2026
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$52.8 |
$147,840 |
|
2/19/2026
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$52.6 |
$111,049 |
|
2/19/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$52.6 |
$366,325 |
|
1/22/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$60.2 |
$3,613,800 |
|
1/22/2026
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$60.2 |
$2,104,965 |
|
1/20/2026
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$51.9 |
$1,552,498 |
|
1/6/2026
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$60.1 |
$1,786,636 |
|
12/22/2025
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$56.1 |
$559,549 |
|
10/17/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$67.9 |
$3,456,279 |
|
10/14/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$66.6 |
$71,662 |
|
10/14/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$66.6 |
$282,517 |
|
8/18/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$58.2 |
$760,660 |
|
8/6/2025
|
Buy |
Treco, Douglas A. |
Director |
$57.0 |
$1,140,600 |
|
7/16/2025
|
Buy |
George, Simeon |
Director |
$52.0 |
$51,499,918 |
|
5/29/2025
|
Sell |
Patel, Naimish |
Chief Medical Officer |
$35.9 |
$141,316 |
|
4/3/2025
|
Buy |
Patel, Naimish |
Chief Medical Officer |
$33.0 |
$49,704 |
|
3/21/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$41.2 |
$131,318 |
|
3/21/2025
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$41.2 |
$90,582 |
|
3/21/2025
|
Sell |
Bruno, Julianne |
Chief Operating Officer |
$41.2 |
$70,668 |
|
3/21/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$41.2 |
$413,578 |
|
3/17/2025
|
Sell |
Prasad, Raju |
Chief Financial Officer |
$41.8 |
$157,252 |
|
3/12/2025
|
Sell |
Bruno, Julianne |
Chief Operating Officer |
$43.3 |
$8,231 |
|
3/12/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$43.3 |
$48,345 |
|
3/12/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$43.3 |
$193,294 |
|
3/11/2025
|
Sell |
Bruno, Julianne |
Chief Operating Officer |
$42.4 |
$50,819 |
|
3/11/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$42.4 |
$120,897 |
|
3/11/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$42.4 |
$423,055 |
|
2/26/2025
|
Buy |
Greene, John |
Director |
$44.8 |
$313,948 |
|
2/19/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$54.0 |
$1,379,362 |
|
2/19/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$52.8 |
$102,802 |
|
2/19/2025
|
Sell |
Bruno, Julianne |
Chief Operating Officer |
$52.8 |
$17,582 |
|
2/18/2025
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$55.0 |
$640,782 |
|
2/18/2025
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$53.8 |
$516,691 |
|
12/2/2024
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$55.1 |
$826,565 |
|
11/11/2024
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$55.8 |
$1,668,678 |
|
10/14/2024
|
Sell |
Kulkarni, Samarth |
Chief Executive Officer |
$46.3 |
$198,680 |
|
10/14/2024
|
Sell |
Kasinger, James R. |
General Counsel and Secretary |
$46.3 |
$50,399 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now